David J Kuter (H Al-Samkari, Hanny Al-Samkari)

ORCID

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 117

Top Venues

Blood advances

American journal of hematology

British journal of haematology

Nature reviews. Nephrology

This page only lists publications with an associated author ORCID identifier.

Publications

Shreyash Dalmia, Brian Harnett, David J Kuter, Donald M Arnold
Novel treatments for immune thrombocytopenia: targeting platelet autoantibodies. Expert review of hematology (2024)
Kevin H M Kuo, Rachael F F Grace, Eduard J van Beers, Wilma Barcellini, Andreas Glenthoej, Susanne Holzhauer, Vanessa Beynon, Susan Morris, Junlong Li, Erin Zagadailov, Parija Patel, David J Kuter
Clinically meaningful improvements in patient-reported outcomes in mitapivat-treated patients with pyruvate kinase deficiency. American journal of hematology 99 (7) (2024)
David J Kuter, Alexandra Schifferli, Tomás José González-López
The problem of immune thrombocytopenia refractory to both eltrombopag and romiplostim. British journal of haematology 204 (4) (2024)
David J Kuter
2025 update on clinical trials in immune thrombocytopenia. American journal of hematology (2024)
Kevin H M Kuo, Rachael F F Grace, Eduard J van Beers, Wilma Barcellini, Andreas Glenthoej, Susanne Holzhauer, Vanessa Beynon, Susan Morris, Junlong Li, Erin Zagadailov, Parija Patel, David J Kuter
Clinically meaningful improvements in patient-reported outcomes in mitapivat-treated patients with pyruvate kinase deficiency. American journal of hematology (2024)
Kevin H M Kuo, Rachael F F Grace, Eduard J van Beers, Wilma Barcellini, Andreas Glenthoej, Susanne Holzhauer, Vanessa Beynon, Susan Morris, Junlong Li, Erin Zagadailov, Parija Patel, David J Kuter
Clinically meaningful improvements in patient-reported outcomes in mitapivat-treated patients with pyruvate kinase deficiency. American journal of hematology 99 (7) (2024)
Alessandro Casini, David J Kuter, Catherine P M Hayward, Flora Peyvandi
Haemophilia : the official journal of the World Federation of Hemophilia (2024)
Shreyash Dalmia, Brian Harnett, David J Kuter, Donald M Arnold
Novel treatments for immune thrombocytopenia: targeting platelet autoantibodies. Expert review of hematology (2024)
Eduard J van Beers, David J Kuter, Rachael F F Grace, Wilma Barcellini, Andreas Glenthoej, Melissa DiBacco, Megan Wind-Rotolo, Rengyi Xu, Vanessa Beynon, Parija Patel, John B Porter, Kevin H M Kuo
Mitapivat improves ineffective erythropoiesis and iron overload in adult patients with pyruvate kinase deficiency. Blood advances (2024)
Eduard J van Beers, David J Kuter, Rachael F F Grace, Wilma Barcellini, Andreas Glenthoej, Melissa L DiBacco, Megan Wind-Rotolo, Rengyi Xu, Vanessa Beynon, Parija Patel, John B Porter, Kevin H M Kuo
Mitapivat improves ineffective erythropoiesis and iron overload in adult patients with pyruvate kinase deficiency. Blood advances 8 (10) (2024)
David J Kuter, Alexandra Schifferli, Tomás José González-López
The problem of immune thrombocytopenia refractory to both eltrombopag and romiplostim. British journal of haematology (2024)
Shreyash Dalmia, Brian Harnett, David J Kuter, Donald M Arnold
Novel treatments for immune thrombocytopenia: targeting platelet autoantibodies. Expert review of hematology (2024)
Alessandro Casini, David J Kuter, Catherine Hayward, Flora Peyvandi
Haemophilia : the official journal of the World Federation of Hemophilia (2024)
Daniel Wang, Satoko Ito, Christina J Waldron, Ayesha Butt, Ellen Zhang, Harlan M Krumholz, David J Kuter, George Goshua
Cost-effectiveness of bevacizumab therapy in the care of patients with hereditary hemorrhagic telangiectasia. Blood advances 8 (11) (2024)
Eduard J van Beers, David J Kuter, Rachael F F Grace, Wilma Barcellini, Andreas Glenthoej, Melissa L DiBacco, Megan Wind-Rotolo, Rengyi Xu, Vanessa Beynon, Parija Patel, John B Porter, Kevin H M Kuo
Mitapivat improves ineffective erythropoiesis and iron overload in adult patients with pyruvate kinase deficiency. Blood advances 8 (10) (2024)
Daniel Wang, Satoko Ito, Christina J Waldron, Ayesha Butt, Ellen Zhang, Harlan M Krumholz, David J Kuter, George Goshua
Cost-effectiveness of bevacizumab therapy in the care of patients with hereditary hemorrhagic telangiectasia. Blood advances 8 (11) (2024)
Aaron Cheng, David J Kuter
Impact of Iron Overload on Incidence of Diabetes Mellitus, Cardiac Disease, and Death in Congenital Hemolytic Anemias. Blood advances (2024)
David J Kuter
How I treat bleeding in hereditary hemorrhagic telangiectasia. Blood 144 (9) (2024)
Ellen Zhang, Zain M Virk, Josanna Rodriguez-Lopez, David J Kuter
Hereditary hemorrhagic telangiectasia may be the most morbid inherited bleeding disorder of women. Blood advances (2024)
Eduard J van Beers, David J Kuter, Rachael F F Grace, Wilma Barcellini, Andreas Glenthoej, Melissa L DiBacco, Megan Wind-Rotolo, Rengyi Xu, Vanessa Beynon, Parija Patel, John B Porter, Kevin H M Kuo
Mitapivat improves ineffective erythropoiesis and iron overload in adult patients with pyruvate kinase deficiency. Blood advances 8 (10) (2024)
Daniel Wang, Satoko Ito, Christina J Waldron, Ayesha Butt, Ellen Zhang, Harlan M Krumholz, David J Kuter, George Goshua
Cost-effectiveness of bevacizumab therapy in the care of patients with hereditary hemorrhagic telangiectasia. Blood advances 8 (11) (2024)
Eduard J van Beers, David J Kuter, Rachael F F Grace, Wilma Barcellini, Andreas Glenthoej, Melissa L DiBacco, Megan Wind-Rotolo, Rengyi Xu, Vanessa Beynon, Parija Patel, John B Porter, Kevin H M Kuo
Mitapivat improves ineffective erythropoiesis and iron overload in adult patients with pyruvate kinase deficiency. Blood advances 8 (10) (2024)
Daniel Wang, Satoko Ito, Christina J Waldron, Ayesha Butt, Ellen Zhang, Harlan M Krumholz, David J Kuter, George Goshua
Cost-effectiveness of bevacizumab therapy in the care of patients with hereditary hemorrhagic telangiectasia. Blood advances (2024)
Shreyash Dalmia, Brian Harnett, David J Kuter, Donald M Arnold
Novel treatments for immune thrombocytopenia: targeting platelet autoantibodies. Expert review of hematology 17 (9) (2024)
David J Kuter
How I Treat Bleeding in Hereditary Hemorrhagic Telangiectasia. Blood (2024)
Daniel Wang, Satoko Ito, Christina J Waldron, Ayesha Butt, Ellen Zhang, Harlan M Krumholz, David J Kuter, George Goshua
Cost-effectiveness of bevacizumab therapy in the care of patients with hereditary hemorrhagic telangiectasia. Blood advances 8 (11) (2024)
Ellen Zhang, Zain M Virk, Josanna Rodriguez-Lopez, David J Kuter
Hereditary hemorrhagic telangiectasia may be the most morbid inherited bleeding disorder in women. Blood advances 8 (12) (2024)
David J Kuter
How I treat bleeding in hereditary hemorrhagic telangiectasia. Blood 144 (9) (2024)
Kevin H M Kuo, Rachael F F Grace, Eduard J van Beers, Wilma Barcellini, Andreas Glenthoej, Susanne Holzhauer, Vanessa Beynon, Susan Morris, Junlong Li, Erin Zagadailov, Parija Patel, David J Kuter
Clinically meaningful improvements in patient-reported outcomes in mitapivat-treated patients with pyruvate kinase deficiency. American journal of hematology 99 (7) (2024)
David J Kuter, Raj S Kasthuri, Vivek N Iyer, Allyson M Pishko, Jake E Decker, Clifford R Weiss, Kevin J Whitehead, Miles B Conrad, Marc S Zumberg, Jenny Y Zhou, Joseph Parambil, Derek Marsh, Marianne Clancy, Lauren Bradley, Lisa Wisniewski, Benjamin A Carper, Sonia M Thomas, Keith R McCrae
Pomalidomide for Epistaxis in Hereditary Hemorrhagic Telangiectasia. The New England journal of medicine 391 (11) (2024)
David J Kuter, Alexandra Schifferli, Tomás José González-López
The problem of immune thrombocytopenia refractory to both eltrombopag and romiplostim. British journal of haematology 204 (4) (2024)
Daniel Wang, Satoko Ito, Christina J Waldron, Ayesha Butt, Ellen Zhang, Harlan M Krumholz, David J Kuter, George Goshua
Cost-effectiveness of bevacizumab therapy in the care of patients with hereditary hemorrhagic telangiectasia. Blood advances (2024)
Ellen Zhang, Zain M Virk, Josanna Rodriguez-Lopez, David J Kuter
Hereditary hemorrhagic telangiectasia may be the most morbid inherited bleeding disorder in women. Blood advances 8 (12) (2024)
Alessandro Casini, David J Kuter, Catherine P M Hayward, Flora Peyvandi
Haemophilia : the official journal of the World Federation of Hemophilia (2024)
Ellen Zhang, Zain M Virk, Josanna Rodriguez-Lopez, David J Kuter
Hereditary hemorrhagic telangiectasia may be the most morbid inherited bleeding disorder of women. Blood advances (2024)
David J Kuter
Mitapivat for phosphofructokinase deficiency. American journal of hematology (2024)
Ellen Zhang, Zain M Virk, Josanna Rodriguez-Lopez, David J Kuter
Hereditary hemorrhagic telangiectasia may be the most morbid inherited bleeding disorder in women. Blood advances 8 (12) (2024)
David J Kuter, Rachael F F Grace, Andreas Glenthoej, Oliver Andres, Wilma Barcellini, Frédéric Galactéros, Kevin H M Kuo, D Mark Layton, Marta Morado Arias, Vip Viprakasit, Yan Dong, Feng Tai, Peter Hawkins, Sarah Gheuens, Jaime Morales-Arias, Keely S Gilroy, John B Porter, Eduard J van Beers
Early-onset reduced bone mineral density in patients with pyruvate kinase deficiency. American journal of hematology 98 (3) (2023)
David J Kuter, James B Bussel
Common-sense combination therapy in refractory immune thrombocytopaenia. British journal of haematology (2023)
Andrew B Song, David J Kuter
Emerging data on thrombopoietin receptor agonists for management of chemotherapy-induced thrombocytopenia. Expert review of hematology (2023)
Naoka Murakami, Robert Hayden, Thomas E Hills, David J Kuter, Jonathan Casey, Lorenzo Del Sorbo, Patrick R Lawler, Meghan E Sise, David E Leaf
Author Correction: Therapeutic advances in COVID-19. Nature reviews. Nephrology (2023)
David J Kuter, Rachael F F Grace, Andreas Glenthoej, Oliver Andres, Wilma Barcellini, Frédéric Galactéros, Kevin H M Kuo, D Mark Layton, Marta Morado Arias, Vip Viprakasit, Yan Dong, Feng Tai, Peter Hawkins, Sarah Gheuens, Jaime Morales-Arias, Keely S Gilroy, John B Porter, Eduard J van Beers
Early-onset reduced bone mineral density in patients with pyruvate kinase deficiency. American journal of hematology 98 (3) (2023)
Brody Foy, Jonathan A Stefely, Pavan K Bendapudi, Robert P Hasserjian, David J Kuter, Abner Louissaint, Megan Fitzpatrick, Bailey Hutchison, Christopher Mow, Julia Collins, Hasmukh Patel, Chhaya Patel, Nikita Patel, Samantha Ho, Richard M Kaufman, Walter 'Sunny' Dzik, John M Higgins, Robert S Makar
Computer vision quantitation of erythrocyte shape abnormalities provides diagnostic, prognostic, and mechanistic insight. Blood advances (2023)
Naoka Murakami, Robert Hayden, Thomas E Hills, David J Kuter, Jonathan Casey, Lorenzo Del Sorbo, Patrick R Lawler, Meghan E Sise, David E Leaf
Author Correction: Therapeutic advances in COVID-19. Nature reviews. Nephrology (2023)
Naoka Murakami, Robert Hayden, Thomas E Hills, David J Kuter, Jonathan Casey, Lorenzo Del Sorbo, Patrick R Lawler, Meghan Sise, David E Leaf
Reply to 'Use of convalescent plasma in the treatment of COVID-19'. Nature reviews. Nephrology (2023)
David J Kuter, Rachael F F Grace, Andreas Glenthoej, Oliver Andres, Wilma Barcellini, Frédéric Galactéros, Kevin H M Kuo, D Mark Layton, Marta Morado Arias, Vip Viprakasit, Yan Dong, Feng Tai, Peter Hawkins, Sarah Gheuens, Jaime Morales-Arias, Keely S Gilroy, John B Porter, Eduard J van Beers
Early-onset reduced bone mineral density in patients with pyruvate kinase deficiency. American journal of hematology (2023)
David J Kuter, Ellis J Neufeld
Novel therapeutics and future directions for refractory immune thrombocytopenia. British journal of haematology 203 (1) (2023)
Zain M Virk, Rebecca K Leaf, David J Kuter, Katayoon Goodarzi, Nathan T Connell, Jean Marie Connors, David J Kuter
Avatrombopag for adults with early versus chronic immune thrombocytopenia. American journal of hematology (2023)
David J Kuter, Rachael F F Grace, Andreas Glenthoej, Oliver Andres, Wilma Barcellini, Frédéric Galactéros, Kevin H M Kuo, D Mark Layton, Marta Morado Arias, Vip Viprakasit, Yan Dong, Feng Tai, Peter Hawkins, Sarah Gheuens, Jaime Morales-Arias, Keely S Gilroy, John B Porter, Eduard J van Beers
Early-onset reduced bone mineral density in patients with pyruvate kinase deficiency. American journal of hematology 98 (3) (2023)
Roxana Ola, Josefien Hessels, Adrienne M Hammilll, Cassi Friday, Marianne S Clancy, David J Kuter, Stryder M Meadows, Vivek N Iyer, Rosemary J Akhurst
Executive summary of the 14th HHT international scientific conference. Angiogenesis (2023)
David J Kuter
Even effective drugs require adequately powered trials: Systemic bevacizumab in hereditary hemorrhagic telangiectasia. Journal of internal medicine (2023)
Naoka Murakami, Robert Hayden, Thomas E Hills, David J Kuter, Jonathan Casey, Lorenzo Del Sorbo, Patrick R Lawler, Meghan Sise, David E Leaf
Reply to 'Use of convalescent plasma in the treatment of COVID-19'. Nature reviews. Nephrology (2023)
Naoka Murakami, Robert Hayden, Thomas E Hills, David J Kuter, Jonathan Casey, Lorenzo Del Sorbo, Patrick R Lawler, Meghan E Sise, David E Leaf
Author Correction: Therapeutic advances in COVID-19. Nature reviews. Nephrology (2023)
Zain M Virk, T Lee Richardson, David J Kuter
Antithrombotic therapy for atrial fibrillation in hereditary hemorrhagic telangiectasia. Journal of thrombosis and thrombolysis (2023)
Naoka Murakami, Robert Hayden, Thomas E Hills, David J Kuter, Jonathan Casey, Lorenzo Del Sorbo, Patrick R Lawler, Meghan Sise, David E Leaf
Reply to 'Use of convalescent plasma in the treatment of COVID-19'. Nature reviews. Nephrology 19 (4) (2023)
David J Kuter, Rachael F F Grace, Andreas Glenthoej, Oliver Andres, Wilma Barcellini, Frédéric Galactéros, Kevin H M Kuo, D Mark Layton, Marta Morado Arias, Vip Viprakasit, Yan Dong, Feng Tai, Peter Hawkins, Sarah Gheuens, Jaime Morales-Arias, Keely S Gilroy, John B Porter, Eduard J van Beers
Early-onset reduced bone mineral density in patients with pyruvate kinase deficiency. American journal of hematology 98 (3) (2023)
David J Kuter, Rachael F F Grace, Andreas Glenthoej, Oliver Andres, Wilma Barcellini, Frédéric Galactéros, Kevin H M Kuo, D Mark Layton, Marta Morado Arias, Vip Viprakasit, Yan Dong, Feng Tai, Peter Hawkins, Sarah Gheuens, Jaime Morales-Arias, Keely S Gilroy, John B Porter, Eduard J van Beers
Early-onset reduced bone mineral density in patients with pyruvate kinase deficiency. American journal of hematology (2023)
David J Kuter, Debbie Jiang, Terry Gernsheimer, Howard Liebman, Susie Lee, Matthew Wojdyla, Michael Vredenburg, Adam Cuker
Adults with immune thrombocytopenia who switched to avatrombopag following prior treatment with eltrombopag or romiplostim: A multicentre US study. British journal of haematology 197 (3) (2022)
David J Kuter
Doxycycline for bleeding in hereditary hemorrhagic telangiectasia: When low-hanging fruit meets inconvenient data. Journal of thrombosis and haemostasis : JTH 20 (5) (2022)
Nathan W Watson, Seth A Wander, Joseph J Shatzel, David J Kuter
Venous and arterial thrombosis associated with abemaciclib therapy for metastatic breast cancer. Cancer 128 (17) (2022)
Andrew B Song, David J Kuter
An evaluation of mitapivat for the treatment of hemolytic anemia in adults with pyruvate kinase deficiency. Expert review of hematology 15 (10) (2022)
David J Kuter
Platelet clump visible to the naked eye in type 2B von Willebrand disease. Blood 138 (25) (2022)
Orly Leiva, Umberto Campia, Julia Snyder, Briana M Barns, Samantha Rizzo, Candrika D Khairani, Andrew Brunner, David J Kuter, Rebecca Karp Leaf, Rachel P Rosovsky, Katayoon Goodarzi, Larissa Bornikova, Amir Fathi, Samuel Z Goldhaber, Gabriela Hobbs, Gregory Piazza
Patients with myeloproliferative neoplasms and COVID-19 have increased rates of arterial thrombosis. Research and practice in thrombosis and haemostasis 6 (5) (2022)
Andrew B Song, David J Kuter
An updated evaluation of avatrombopag for the treatment of chronic immune thrombocytopenia. Expert review of clinical immunology 18 (8) (2022)
David J Kuter, Whitney Eng
A precision medicine approach to hereditary hemorrhagic telangiectasia and complex vascular anomalies. Journal of thrombosis and haemostasis : JTH 20 (5) (2022)
Naoka Murakami, Robert Hayden, Thomas E Hills, David J Kuter, Jonathan Casey, Lorenzo Del Sorbo, Patrick R Lawler, Meghan E Sise, David E Leaf
Therapeutic advances in COVID-19. Nature reviews. Nephrology (2022)
Zain M Virk, Andrew B Song, Yousef R Badran, David J Kuter
Systemic bevacizumab as salvage therapy for persistent severe bleeding and anemia in heyde syndrome following aortic valve replacement. Journal of thrombosis and thrombolysis 54 (2) (2022)
Abraham Z Cheloff, David J Kuter
Romiplostim for PARP inhibitor-induced thrombocytopenia in solid tumor malignancies. Platelets 33 (8) (2022)
Nardeen Essam Ayad, Rachael F F Grace, David J Kuter, David J Kuter
Long-Term Risk of Developing Immune Thrombocytopenia and Hematologic Neoplasia in Adults with Mild Thrombocytopenia. Blood (2022)
David J Kuter, Frédéric Galactéros, Andreas Glenthoej, Jennifer A Rothman, Oliver Andres, Rachael F Grace, Marta Morado-Arias, D Mark Layton, Koichi Onodera, Madeleine Verhovsek, Wilma Barcellini, Satheesh Chonat, Malia P Judge, Erin Zagadailov, Rengyi Xu, Peter Hawkins, Vanessa Beynon, Sarah Gheuens, Eduard J van Beers, null null
Mitapivat versus Placebo for Pyruvate Kinase Deficiency. The New England journal of medicine 386 (15) (2022)
David J Kuter, John A Glaspy, Robert T Means, Glenn M Chertow, Michael Auerbach
Risks for Anaphylaxis With Intravenous Iron Formulations. Annals of internal medicine 175 (11) (2022)
Nathan W Watson, David J Kuter
Thrombotic and bleeding risk of angiogenesis inhibitors in patients with and without malignancy. Journal of thrombosis and haemostasis : JTH 19 (8) (2021)
Abraham Z Cheloff, Andrew B Song, Kristin M D'Silva, David J Kuter
Systemic bevacizumab to facilitate anticoagulation in antiphospholipid syndrome and bleeding gastrointestinal angiodysplasia. Journal of thrombosis and thrombolysis (2021)
David J Kuter, Shruti Gupta, Rebecca Karp Leaf, Wei Wang, Rachel P Rosovsky, Samantha K Brenner, Salim Salim Hayek, Hanna P Berlin, Rajat Kapoor, Shahzad Shaefi, Michal L Melamed, Anne Sutherland, Jared Radbel, Adam Green, Brian T Garibaldi, Anand Srivastava, Amanda Leonberg-Yoo, Alexandre M Shehata, Jennifer E Flythe, Arash Rashidi, Nitender Goyal, Lili Chan, Kusum S Mathews, S Susan Hedayati, Rajany Dy, Stephanie M Toth-Manikowski, Jingjing Zhang, Mary Mallappallil, Roberta E Redfern, Amar D Bansal, Samuel A P Short, Mark G Vangel, Andrew J Admon, Matthew W Semler, Kenneth A Bauer, Miguel A Hernán, David E Leaf, null null
Thrombosis, Bleeding, and the Observational Effect of Early Therapeutic Anticoagulation on Survival in Critically Ill Patients With COVID-19. Annals of internal medicine 174 (5) (2021)
Andrew B Song, Rahul Sakhuja, Nancy M Gracin, Ronald Weinger, Raj S Kasthuri, David J Kuter
Systemic bevacizumab for refractory bleeding and transfusion-dependent anemia in Heyde syndrome. Blood advances 5 (19) (2021)
Eun-Ju Lee, David J Kuter
TPO versus TPO: the good, the bad, and the to be determined. British journal of haematology 195 (5) (2021)
Andrew B Song, Katayoon Goodarzi, Rebecca Karp Leaf, David J Kuter, David J Kuter
Thrombopoietin level predicts response to treatment with romiplostim in chemotherapy-induced thrombocytopenia. American journal of hematology 96 (12) (2021)
David J Kuter
Recognition and management of vascular lesions in von Willebrand disease. Journal of thrombosis and haemostasis : JTH 19 (9) (2021)
Zain M Virk, Arpan A Patel, Rebecca K Leaf, David J Kuter
Predictors of mortality and outcomes of liver transplant in spur cell hemolytic anemia. American journal of hematology 96 (12) (2021)
David J Kuter, Eduard J van Beers
Mitapivat, a novel pyruvate kinase activator, for the treatment of hereditary hemolytic anemias. Therapeutic advances in hematology 12 (2021)
David J Kuter, Eduard J van Beers, D Holmes Morton, Stefan Eber, Satheesh Chonat, Kevin H M Kuo, Nina Kollmar, Heng Wang, Vicky Breakey, Sujit Sheth, Mukta Sharma, Peter W Forbes, Robert J Klaassen, Rachael F F Grace
Health-Related Quality of Life and Fatigue in Children and Adults with Pyruvate Kinase Deficiency. Blood advances (2021)
Emily M Harris, Kirsty Hillier, David J Kuter, Laura Berbert, Rachael F F Grace
Response to rituximab in children and adults with immune thrombocytopenia (ITP). Research and practice in thrombosis and haemostasis 5 (6) (2021)
Albert K Park, Anem Waheed, Deborah A Forst, David J Kuter
Characterization and Prognosis of Temozolomide-Induced Aplastic Anemia in Patients with Central Nervous System Malignancies. Neuro-oncology (2021)
Joseph G Parambil, James R Gossage, Keith R McCrae, Troy D Woodard, K V Narayanan Menon, Kasi L Timmerman, Douglas P Pederson, Dennis L Sprecher, David J Kuter
Pazopanib for severe bleeding and transfusion-dependent anemia in hereditary hemorrhagic telangiectasia. Angiogenesis (2021)
Eun-Ju Lee, Marina Beltrami Moreira, David J Kuter, Adam Cuker, Jennifer DiRaimo, Terry Gernsheimer, Alexandra Kruse, Craig M Kessler, Caroline Kruse, Andrew D Leavitt, Alfred Ian Lee, Howard Allen Liebman, Adrian C Newland, Ashley E Ray, Michael D Tarantino, Jecko Thachil, David J Kuter, Douglas B Cines, James B Bussel
SARS-CoV-2 Vaccination and Immune Thrombocytopenia in de novo and pre-existing ITP patients. Blood (2021)
David J Kuter, Rebecca Karp Leaf, Katayoon Goodarzi
Transient Thrombocytopenia With Glycoprotein-Specific Platelet Autoantibodies After Ad26.COV2.S Vaccination: A Case Report. Annals of internal medicine 174 (11) (2021)
Sanjay R V Gadi, Patricia A R Brunker, David J Kuter, David B Sykes, Rebecca R Saff, Janet Lo, Pavan Bendapudi, David E Leaf, Rebecca Karp Leaf
Severe autoimmune hemolytic anemia following receipt of SARS-CoV-2 mRNA vaccine. Transfusion 61 (11) (2021)
Nardeen Essam Ayad, Rachael F F Grace, David J Kuter
Thrombopoietin receptor agonists and rituximab for treatment of pediatric immune thrombocytopenia: A systematic review and meta-analysis of prospective clinical trials. Pediatric blood & cancer 69 (3) (2021)
Fei Song, David J Kuter
Management of Adult Patients with Immune Thrombocytopenia (ITP): A Review on Current Guidance and Experience from Clinical Practice. Journal of blood medicine 12 (2021)
David J Kuter, Alexandria Cronin, Donald M Arnold, Francesco Rodeghiero, Rachael F F Grace
Extensive variability in platelet, bleeding, and QOL outcome measures in adult and pediatric ITP: Communication from the ISTH SSC subcommittee on platelet immunology. Journal of thrombosis and haemostasis : JTH 19 (9) (2021)
David J Kuter, Arpan A Patel
How to focus our efforts in improving prognostic disclosure in oncology. Cancer 126 (11) (2020)
David J Kuter, Rakhi P Naik, Neil A Zakai
A hematologic support score for longitudinal measurement of blood and iron requirements in hereditary hemorrhagic telangiectasia and other chronic bleeding disorders. Research and practice in thrombosis and haemostasis 4 (8) (2020)
David J Kuter, Stacy E Croteau
Beliefs, opinions and impact of emicizumab in haemophilia A patients: A National US Survey Study. Haemophilia : the official journal of the World Federation of Hemophilia 27 (2) (2020)
Hanny Al-Samkari, Rachael F Grace, David J Kuter
The role of romiplostim for pediatric patients with immune thrombocytopenia. Therapeutic advances in hematology 11 (2020)
David J Kuter, Hasan A Albitar, Scott E Olitsky, Marianne S Clancy, Vivek N Iyer
An international survey to evaluate systemic bevacizumab for chronic bleeding in hereditary haemorrhagic telangiectasia. Haemophilia : the official journal of the World Federation of Hemophilia 26 (6) (2020)
David J Kuter, Eduard J van Beers, D Holmes Morton, Wilma Barcellini, Stefan W Eber, Bertil Glader, Hassan M Yaish, Satheesh Chonat, Kevin H M Kuo, Nina Kollmar, Jenny M Despotovic, Dagmar Pospíšilová, Christine M Knoll, Janet L Kwiatkowski, Yves D Pastore, Alexis A Thompson, Marcin W Wlodarski, Yaddanapudi Ravindranath, Jennifer A Rothman, Heng Wang, Susanne Holzhauer, Vicky R Breakey, Madeleine M Verhovsek, Joachim Kunz, Sujit Sheth, Mukta Sharma, Melissa J Rose, Heather A Bradeen, Melissa N McNaull, Kathryn Addonizio, Hasan Al-Sayegh, Wendy B London, Rachael F F Grace
Characterization of the severe phenotype of pyruvate kinase deficiency. American journal of hematology (2020)
Marie E Faughnan, Johannes J Mager, Steven W Hetts, Valerie A Palda, Kelly Lang-Robertson, Elisabetta Buscarini, Erik Deslandres, Raj S Kasthuri, Andrea Lausman, David Poetker, Felix A Ratjen, Mark S Chesnutt, Marianne S Clancy, Kevin J Whitehead, David J Kuter, Murali M Chakinala, Miles B Conrad, Daniel Cortes, Claudia Crocione, Jama Darling, Els de Gussem, Carol Derksen, Sophie Dupuis-Girod, Patrick Foy, Urban W Geisthoff, James R Gossage, Adrienne M Hammilll, Ketil Heimdal, Katharine Henderson, Vivek N Iyer, Anette Drøhse Kjeldsen, Masaki Komiyama, Kevin Korenblatt, Jamie McDonald, Jack McMahon, Justin P McWilliams, Mary E Meek, Meir Mei Zahav, Scott Olitsky, Sara Palmer, Rose Pantalone, Jay F Piccirillo, Beth Plahn, Mary E M Porteous, Marco C Post, Ivan Radovanovic, Paul J Rochon, Josanna Rodriguez-Lopez, Carlo Sabba, Marcelo Martín Serra, Claire L Shovlin, Dennis Sprecher, Andrew J White, Ingrid Winship, Roberto Zarrabeitia
Second International Guidelines for the Diagnosis and Management of Hereditary Hemorrhagic Telangiectasia. Annals of internal medicine 173 (12) (2020)
Abraham Z Cheloff, David J Kuter, David J Kuter
Serum complement levels in immune thrombocytopenia: Characterization and relation to clinical features. Research and practice in thrombosis and haemostasis 4 (5) (2020)
Orly Leiva, Jean M Connors, David J Kuter
Impact of Tumor Genomic Mutations on Thrombotic Risk in Cancer Patients. Cancers 12 (7) (2020)
David J Kuter, Kathryn Addonizio, Bertil Glader, D Holmes Morton, Satheesh Chonat, Alexis A Thompson, Kevin H M Kuo, Yaddanapudi Ravindranath, Heng Wang, Jennifer A Rothman, Janet L Kwiatkowski, Charles Kung, Penelope A Kosinski, Hasan Al-Sayegh, Wendy B London, Rachael F F Grace
The pyruvate kinase (PK) to hexokinase enzyme activity ratio and erythrocyte PK protein level in the diagnosis and phenotype of PK deficiency. British journal of haematology 192 (6) (2020)

David J Kuter.css-eqlu8i{font-size:small;padding-left:4px;} (H Al-Samkari, Hanny Al-Samkari)

Publication Activity (10 Years)

Top Topics

Top Venues

David J Kuter (H Al-Samkari, Hanny Al-Samkari)